MCKINNEY ROBERT A 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 20, 2011
Insider Transaction Report
Form 4
MCKINNEY ROBERT A
Chief Financial Officer
Transactions
- Sale
Common Stock
2011-06-17$7.50/sh−3,000$22,500→ 42,444 total
Footnotes (1)
- [F1]Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer.